Australië - Engels - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ranitidine hydrochloride -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - ranitidine hydrochloride -

Verenigde Staten - Engels - NLM (National Library of Medicine)

contract pharmacy services-pa - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - ranitidine tablets are indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of rantidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acuter ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out

Australië - Engels - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ranitidine hydrochloride -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ranitidine hydrochloride -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - ranitidine hydrochloride -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - ranitidine hydrochloride -

Verenigde Staten - Engels - NLM (National Library of Medicine)

physician therapeutics llc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - indications and usage ranitidine tablets, usp is indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulce

Verenigde Staten - Engels - NLM (National Library of Medicine)

wal-mart stores inc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - acid reducer - relieves heartburn associated with acid indigestion and sour stomach - prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Verenigde Staten - Engels - NLM (National Library of Medicine)

wal-mart stores, inc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 75 mg - acid reducer